Fingerprint
Dive into the research topics of 'Follow-up results of a phase II study of ibritumomab tiuxetan radioimmunotherapy in patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma and mild thrombocytopenia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically